openPR Logo
Press release

Shawn Younai: The Multi-Millionaire Entrepreneur Who's Turned Peptide Hackers into LA's Premier Destination for Research-Use Peptides

07-14-2025 06:00 PM CET | Health & Medicine

Press release from: ABNewswire

Shawn Younai: The Multi-Millionaire Entrepreneur Who's Turned

Los Angeles, CA - 14 Juy, 2025 - Shawn Younai, famously known as the Travel Hacker of The Year (TravelsHQ), is now not only gaining fame for personal fitness, but also being highlighted an emerging face in health research. Valued at $25 million, Peptide Hackers is today one of the best in the business of the research peptide market and one of the leading suppliers in Los Angeles.

It's only natural a travel hacker gets into biohacking.

Peptide Hackers [http://www.peptidehackers.com] offers only the highest quality research peptides which are intended for laboratory use only. These chemicals are NOT intended for human consumption and are meant for research purposes only. The company follow all the regulations and transparency about the purity, testing and where the oil come from.

"Everything that we do offer is for qualified research professionals and not for clinical or personal use," Younai said. "We're out to provide the scientific community with uniform, high quality materials."

"It has helped a lot," says Shawn on being known as an expert in systems for credit, travel, and now for science with Peptide Hackers. His business model emphasizes labeling products clearly, having them third-party tested and ensuring reliable fulfillment; that model has helped gain the trust of university labs, independent researchers, and contract organizations.

As Younai puts it:

"The same intellectual approach that led me to reverse-engineer credit algorithms and reward systems now helps me run a research company that values precision and compliance."

As a go-to source for compounds that one would use in non-clinical investigative practice, Peptide Hackers has become a leading provider of peptides such as BPC-157, CJC-1295, and Ipamorelin all of which are to be sold exclusively for research purposes in the U.S.

Key Compliance Points:

*
This product is not for human or veterinary use

*
These statements have not been evaluated by the Food and Drug Administration; This product is not intended to diagnose, treat, cure or prevent any disease

*
All products are labeled with "For Laboratory Research Use Only"

For media interview requests or PR with Shawn Younai - please reach out to:

Media Contact:

Name: Kelsie Cromwell

Email: info@traveleshq.com [mailto:info@traveleshq.com]

Phone: 1-561-513-8860

About Peptide Hackers:

Peptide Hackers is known as a Peptide Supplier out of Los Angeles, California that serves Research Chemicals around the Country to Research SIte Holders. All products are sold as research materials. The use of the company's product for any of these purposes might result in the a different effect that senseo will not be held accountable for.

Advice is for information only and should not replace medical care. All product is for qualified research professionals.

Media Contact
Company Name: peptide hackers
Contact Person: Kevin Sands
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=shawn-younai-the-multimillionaire-entrepreneur-whos-turned-peptide-hackers-into-las-premier-destination-for-researchuse-peptides]
Country: United States
Website: http://www.peptidehackers.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Shawn Younai: The Multi-Millionaire Entrepreneur Who's Turned Peptide Hackers into LA's Premier Destination for Research-Use Peptides here

News-ID: 4103459 • Views:

More Releases from ABNewswire

DMB Plumbing & Heating Urges Homeowners to Schedule Pre-Winter Heating Inspections
DMB Plumbing & Heating Urges Homeowners to Schedule Pre-Winter Heating Inspectio …
DMB Plumbing & Heating Inc. of Bridgewater, led by Dean Blanchard, is urging homeowners to schedule pre-winter heating inspections. As temperatures in Massachusetts begin to dip and residents prepare their homes for another New England winter, DMB Plumbing & Heating Inc., a locally owned and operated company based in Bridgewater, is reminding homeowners of the importance of pre-winter heating inspections. Founded and operated by Dean Blanchard, DMB Plumbing & Heating has long
BitX Capital Champions Merchant Cash Advance as a Flexible Funding Alternative for Modern Businesses
BitX Capital Champions Merchant Cash Advance as a Flexible Funding Alternative f …
About BitX Capital: Founded in 2013, BitX Capital specializes in connecting small and medium-sized businesses with customized funding solutions. Leveraging deep market knowledge and led by a veteran team, BitX Capital simplifies the complex world of business lending, empowering businesses with the capital needed for growth and stability. October 9, 2025 - BitX Capital, a trusted leader in small business financing, today announcement underscored the value of the Merchant Cash Advance
Cell and Gene Therapy in Parkinson's Disease Market to Experience Notable Growth in Forecast Span by 2034, DelveInsight Predicts | Prevail Therapeutics (Eli Lilly), MeiraGTx, Hope Biosciences
Cell and Gene Therapy in Parkinson's Disease Market to Experience Notable Growth …
The Key Cell and Gene Therapy in Parkinson's Disease Companies in the market include - Prevail Therapeutics (Eli Lilly), MeiraGTx, Hope Biosciences, and others. DelveInsight's "Cell and Gene Therapy in Parkinson's Disease Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Cell and Gene Therapy in Parkinson's Disease, historical and forecasted epidemiology as well as the Cell and Gene Therapy in Parkinson's Disease market trends in the
Polycythemia Vera Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Roche, Fujifilm Holdings Corp, Hangzhou Bensheng Pharma, Protagonist Therapeu
Polycythemia Vera Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Polycythemia Vera pipeline constitutes 8+ key companies continuously working towards developing 10+ Polycythemia Vera treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Polycythemia Vera Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed

All 5 Releases